Autopsy report · NCT00616343

Zonisamide in the Treatment of Essential Tremor

“Principal Investigator left the study site on December 28, 2012.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years 8 months after it had already started.
• Ran for about 9 years 6 months before it stopped.
• 9 participants enrolled.
• Results were posted on the registry 1 year 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Loma Linda University

Sponsor type

University, hospital or other

Conditions

Essential Tremor

Interventions

Zonisamide

Participants

9

Trials that died the same way

• Wearable Auscultation Device Validation in Children
  “The Principal Investigator is departing from the study site.” (84% match in meaning)
• Staged Bilateral Carpal Tunnel Release: Which Side Hurts More?
  “The researcher and principal investigator working on this study left the institution.” (79% match in meaning)
• Surgical Field Bacterial Contamination in Primary Total Hip (THA) and Knee (TKA) Arthroplasty
  “Study principal investigator left the organization” (79% match in meaning)
• Blood Flow Restriction Training Following Glenoid Labral Repair
  “Principal Investigator left research facility.” (77% match in meaning)
• TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory
  “The study principle investigator left the institution.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.